{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:25:38Z","timestamp":1794435938585,"version":"4.9.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007520","name":"Nationwide Children's Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007520","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.omtn.2026.102881","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T15:59:50Z","timestamp":1772207990000},"page":"102881","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Safety, efficacy, and distal nerve Schwann cell biodistribution in mice and NHPs to support translation of AAV9 RNAi therapy for CMT1A"],"prefix":"10.1016","volume":"37","author":[{"given":"Marina","family":"Stavrou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay M.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merlin P.","family":"Thangaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah K.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexia","family":"Kagiava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Revekka","family":"Papacharalambous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"McAllister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Zender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nizar Y.","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Bilal","family":"Bayazit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Heslegrave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Tryfonos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Salzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kleopas A.","family":"Kleopa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5135-4317","authenticated-orcid":false,"given":"Scott Q.","family":"Harper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2026.102881_bib1","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/14737175.2025.2470980","article-title":"Charcot-Marie-Tooth disease: a review of clinical developments and its management - What's new in 2025?","volume":"25","author":"De Grado","year":"2025","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.omtn.2026.102881_bib2","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1177\/22143602241313118","article-title":"Prevalence and incidence rates of 17 neuromuscular disorders: An updated review of the literature","volume":"12","author":"Deenen","year":"2025","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.omtn.2026.102881_bib3","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/jns.12543","article-title":"Charcot-Marie-Tooth neuropathies: Current gene therapy advances and the route toward translation","volume":"28","author":"Stavrou","year":"2023","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.omtn.2026.102881_bib4","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/hmg\/7.3.449","article-title":"Correlation between varying levels of PMP22 expression and the degree of demyelination and reduction in nerve conduction velocity in transgenic mice","volume":"7","author":"Huxley","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2026.102881_bib5","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ng0692-166","article-title":"The peripheral myelin gene PMP-22\/GAS-3 is duplicated in Charcot-Marie-Tooth disease type 1A","volume":"1","author":"Valentijn","year":"1992","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtn.2026.102881_bib6","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/ana.410350412","article-title":"Elevated expression of messenger RNA for peripheral myelin protein 22 in biopsied peripheral nerves of patients with Charcot-Marie-Tooth disease type 1A","volume":"35","author":"Yoshikawa","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtn.2026.102881_bib7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s42003-021-01839-2","article-title":"Squalenoyl siRNA PMP22 nanoparticles are effective in treating mouse models of Charcot-Marie-Tooth disease type 1 A","volume":"4","author":"Boutary","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.omtn.2026.102881_bib8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.5607\/en.2019.28.2.279","article-title":"miR-381 Attenuates Peripheral Neuropathic Phenotype Caused by Overexpression of PMP22","volume":"28","author":"Lee","year":"2019","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.omtn.2026.102881_bib9","first-page":"130","article-title":"Targeted PMP22 TATA-box editing by CRISPR\/Cas9 reduces demyelinating neuropathy of Charcot-Marie-Tooth disease type 1A in mice","volume":"48","author":"Lee","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.102881_bib10","doi-asserted-by":"crossref","DOI":"10.1172\/JCI159814","article-title":"A translatable RNAi-driven gene therapy silences PMP22\/Pmp22 genes and improves neuropathy in CMT1A mice","volume":"132","author":"Stavrou","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtn.2026.102881_bib11","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1172\/JCI96499","article-title":"PMP22 antisense oligonucleotides reverse Charcot-Marie-Tooth disease type 1A features in rodent models","volume":"128","author":"Zhao","year":"2018","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtn.2026.102881_bib12","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1038\/s41467-021-22593-3","article-title":"AAV2\/9-mediated silencing of PMP22 prevents the development of pathological features in a rat model of Charcot-Marie-Tooth disease 1 A","volume":"12","author":"Gautier","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.102881_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-02694-1","article-title":"Efficacy of AAV serotypes to target Schwann cells after intrathecal and intravenous delivery","volume":"11","author":"Kagiava","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2026.102881_bib14","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/35078107","article-title":"Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells","volume":"411","author":"Elbashir","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.102881_bib15","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1101\/gad.862301","article-title":"RNA interference is mediated by 21- and 22-nucleotide RNAs","volume":"15","author":"Elbashir","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.omtn.2026.102881_bib16","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35888","article-title":"Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans","volume":"391","author":"Fire","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2026.102881_bib17","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1101\/gad.1026102","article-title":"The Argonaute family: tentacles that reach into RNAi, developmental control, stem cell maintenance, and tumorigenesis","volume":"16","author":"Carmell","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.omtn.2026.102881_bib18","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1126\/science.1128813","article-title":"Argonaute slicing is required for heterochromatic silencing and spreading","volume":"313","author":"Irvine","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.102881_bib19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.sbi.2006.01.010","article-title":"Argonaute and RNA--getting into the groove","volume":"16","author":"Song","year":"2006","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.omtn.2026.102881_bib20","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.ymthe.2020.04.007","article-title":"RNAi-Based Gene Therapy Rescues Developmental and Epileptic Encephalopathy in a Genetic Mouse Model","volume":"28","author":"Aimiuwu","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2026.102881_bib21","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1073\/pnas.0501507102","article-title":"RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model","volume":"102","author":"Harper","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2026.102881_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2014.13","article-title":"RNAi-mediated Gene Silencing of Mutant Myotilin Improves Myopathy in LGMD1A Mice","volume":"3","author":"Liu","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2026.102881_bib23","doi-asserted-by":"crossref","first-page":"5568","DOI":"10.1172\/JCI130600","article-title":"Allele-specific RNA interference prevents neuropathy in Charcot-Marie-Tooth disease type 2D mouse models","volume":"129","author":"Morelli","year":"2019","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtn.2026.102881_bib24","doi-asserted-by":"crossref","first-page":"7128","DOI":"10.1038\/s41467-021-27430-1","article-title":"Human miRNA miR-675 inhibits DUX4 expression and may be exploited as a potential treatment for Facioscapulohumeral muscular dystrophy","volume":"12","author":"Saad","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.102881_bib25","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/mt.2012.68","article-title":"RNA interference inhibits DUX4-induced muscle toxicity in vivo: implications for a targeted FSHD therapy","volume":"20","author":"Wallace","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2026.102881_bib26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.omtm.2017.12.005","article-title":"Pre-clinical Safety and Off-Target Studies to Support Translation of AAV-Mediated RNAi Therapy for FSHD","volume":"8","author":"Wallace","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2026.102881_bib27","doi-asserted-by":"crossref","first-page":"W451","DOI":"10.1093\/nar\/gkl243","article-title":"RNAhybrid: microRNA target prediction easy, fast and flexible","volume":"34","author":"Kr\u00fcger","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.102881_bib28","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.omtm.2022.01.013","article-title":"Characterization of AAV-mediated dorsal root ganglionopathy","volume":"24","author":"Buss","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2026.102881_bib29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ymthe.2024.11.029","article-title":"Dorsal root ganglion toxicity after AAV intra-CSF delivery of a RNAi expression construct into non-human primates and mice","volume":"33","author":"Hawley","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2026.102881_bib30","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1089\/hum.2020.167","article-title":"Adeno-Associated Virus-Induced Dorsal Root Ganglion Pathology","volume":"31","author":"Hordeaux","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2026.102881_bib31","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1089\/hum.2019.012","article-title":"Safe and Sustained Expression of Human Iduronidase After Intrathecal Administration of Adeno-Associated Virus Serotype 9 in Infant Rhesus Monkeys","volume":"30","author":"Hordeaux","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2026.102881_bib32","doi-asserted-by":"crossref","first-page":"eadn3259","DOI":"10.1126\/sciadv.adn3259","article-title":"Cerebrospinal fluid flow extends to peripheral nerves further unifying the nervous system","volume":"10","author":"Ligocki","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omtn.2026.102881_bib33","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00401-010-0783-x","article-title":"Homeostatic regulation of the endoneurial microenvironment during development, aging and in response to trauma, disease and toxic insult","volume":"121","author":"Mizisin","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.omtn.2026.102881_bib34","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1186\/1756-0500-7-714","article-title":"Harvesting the maximum length of sciatic nerve from adult mice: a step-by-step approach","volume":"7","author":"Bala","year":"2014","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.omtn.2026.102881_bib35","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa2307952","article-title":"Intrathecal Gene Therapy for Giant Axonal Neuropathy","volume":"390","author":"Bharucha-Goebel","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2026.102881_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2024.e00437","article-title":"Clinical decision making around commercial use of gene and genetic therapies for spinal muscular atrophy","volume":"21","author":"Waldrop","year":"2024","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.omtn.2026.102881_bib37","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1093\/brain\/awp113","article-title":"PMP22 expression in dermal nerve myelin from patients with CMT1A","volume":"132","author":"Katona","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.omtn.2026.102881_bib38","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/s41587-023-01974-7","article-title":"Integrated vector genomes may contribute to long-term expression in primate liver after AAV administration","volume":"42","author":"Greig","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2026.102881_bib39","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1177\/01926233221101309","article-title":"Intrathecal sc-AAV9-CB-GFP: Systemic Distribution Predominates Following Single-Dose Administration in Cynomolgus Macaques","volume":"50","author":"Meseck","year":"2022","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.omtn.2026.102881_bib40","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.omtm.2018.12.001","article-title":"Kinetics and MR-Based Monitoring of AAV9 Vector Delivery into Cerebrospinal Fluid of Nonhuman Primates","volume":"13","author":"Ohno","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2026.102881_bib41","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.omtm.2020.04.001","article-title":"Intra-CSF AAV9 and AAVrh10 Administration in Nonhuman Primates: Promising Routes and Vectors for Which Neurological Diseases?","volume":"17","author":"Bey","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2026.102881_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.1091","article-title":"Lumbar Intrathecal Injection in Adult and Neonatal Mice","volume":"4","author":"Stavrou","year":"2024","journal-title":"Curr. Protoc."},{"key":"10.1016\/j.omtn.2026.102881_bib43","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41434-021-00250-0","article-title":"AAV9-mediated Schwann cell-targeted gene therapy rescues a model of demyelinating neuropathy","volume":"28","author":"Kagiava","year":"2021","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtn.2026.102881_bib44","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1212\/WNL.0000000000003154","article-title":"Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia","volume":"87","author":"Rohrer","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.omtn.2026.102881_bib45","doi-asserted-by":"crossref","first-page":"e518","DOI":"10.1212\/WNL.0000000000004932","article-title":"Plasma neurofilament light chain concentration in the inherited peripheral neuropathies","volume":"90","author":"Sandelius","year":"2018","journal-title":"Neurology"}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126000521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126000521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:29:43Z","timestamp":1794432583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253126000521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2162253126000521"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2026.102881","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety, efficacy, and distal nerve Schwann cell biodistribution in mice and NHPs to support translation of AAV9 RNAi therapy for CMT1A","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2026.102881","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102881"}}